Written question asked by Charlotte Nichols (Labour) on Wednesday, 26 October 2022, in the House of Commons. It was due for an answer on Friday, 28 October 2022. It was answered by Greg Hands (Conservative) on Monday, 7 November 2022 on behalf of the Department for International Trade.
TRIPS Agreement: Coronavirus
- Question
-
To ask the Secretary of State for International Trade, what discussions she has had with (a) The Secretary for Foreign, Commonwealth and Development Affairs, (b) Secretary of State for Business, Energy and Industrial Strategy, (c) The Secretary for Health and Social Care and (d) her G7 counterparts on the potential merits of including covid-19 treatment and diagnostics in the TRIPS Agreement.
- Answer
-
Consultations with other government departments are ongoing on whether the MC12 TRIPS Decision be extended to include COVID-19 diagnostics and therapeutics. UK Government officials will continue to engage with relevant stakeholders, as well as with other World Trade Organization Members at the TRIPS Council. The UK looks forward to making progress in this area and remains committed to engaging constructively.
Secondary information
- Type
- Written question
- Reference
- 72473
- Session
- 2022-23
- Grouped for answer
- Yes
- Subjects
- International cooperation Medical treatments Departmental coordination TRIPS Agreement Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-11-07 16:04:22 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/72473
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/72473
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/72473